|
Volumn 19, Issue 3, 2012, Pages 468-469
|
Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer
|
Author keywords
Avastin; Chemotherapy; Meningioma; Taxol
|
Indexed keywords
BEVACIZUMAB;
ESTROGEN RECEPTOR;
PACLITAXEL;
PROGESTERONE RECEPTOR;
ADULT;
ARTICLE;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER RECURRENCE;
CANCER REGRESSION;
CASE REPORT;
CAUSE OF DEATH;
CLINICAL FEATURE;
FEMALE;
HUMAN;
MENINGIOMA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT FAILURE;
TUMOR VOLUME;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BRAIN;
BREAST NEOPLASMS;
FATAL OUTCOME;
FEMALE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MENINGIOMA;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
|
EID: 84856759361
PISSN: 09675868
EISSN: 15322653
Source Type: Journal
DOI: 10.1016/j.jocn.2011.07.024 Document Type: Article |
Times cited : (19)
|
References (9)
|